Discure Technologies vs Ray Therapeutics

Discure Technologies vs Ray Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Discure Technologies is on 50/100 and Ray Therapeutics on 53/100.

Discure Technologies logo
Discure TechnologiesDevelops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.
Try Discure Technologies
Ray Therapeutics logo
Ray TherapeuticsPioneering vision restoration therapies for severe retinal degenerations.
Try Ray Therapeutics

Where each one leads

Discure Technologies

  • agent readiness: 37/100 against 21/100

Ray Therapeutics

  • our overall score: 53/100 against 50/100
  • domain rating: 29/100 against 4/100
  • funding raised: $243M against $11.0M

At a glance

MeasureDiscure TechnologiesRay Therapeutics
What it isDevelops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.Pioneering vision restoration therapies for severe retinal degenerations.
CategoryHealthcare, Patient Care, Life Sciences, Medical DevicesBiotechnology, Pharmaceuticals, Healthcare, Medical Devices
Sells toBusiness modelB2BB2B
OfferingHardwareServices
Founded20212021
HeadquartersTel Aviv, IsraelBerkeley, USA
StatusActiveActive

Size, funding and growth

MeasureDiscure TechnologiesRay Therapeutics
Employees12Not published
Headcount growthLast 12 months+18.4%Not published
Total funding$11.0M$243M
Latest roundSeries ASeries B
LinkedIn followers1,859Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureDiscure TechnologiesRay Therapeutics
StartupHub scoreOur 0-100 rating50/10053/100
Traction46/10040/100
Team30/10050/100
Search visibility30/10014/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (37/100)F (21/100)
Domain ratingLink authority, 0-1004/10029/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureDiscure TechnologiesRay Therapeutics
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressWordPress
FrameworksJquery, BootstrapJquery
AnalyticsGoogle Analytics 4Google Analytics 4

Discure Technologies vs Ray Therapeutics: common questions

Which is better, Discure Technologies or Ray Therapeutics?

On our 0-100 score Ray Therapeutics rates higher (53/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Discure Technologies and Ray Therapeutics compare on the numbers?

Discure Technologies leads on agent readiness (37/100 against 21/100). Ray Therapeutics leads on our overall score (53/100 against 50/100), domain rating (29/100 against 4/100), funding raised ($243M against $11.0M).

Read the full Discure Technologies review and pricing or the Ray Therapeutics review and pricing. You can also browse other Discure Technologies alternatives we track.